Report an accessibility problem
Engineering  |  FURI
FURI Fall 2018
Health

Optimizing recombinant protein production for domain antibodies: proof-of-concept

Recent studies in traumatic brain injury (TBI) have found a temporal window where therapeutics on the nanometer scale can cross the blood-brain barrier and enter the parenchyma. Developing protein-based therapeutics is attractive for a number of reasons, yet, the production pipeline for high yield and consistent bioactive recombinant proteins is a major obstacle. This project directly addresses this issue and evaluates the potential to use Brevibacillus host to produce biologically active domain antibody proteins for future use in nanoparticle therapeutics.

Portrait of Glenna Embrador

Glenna Embrador

Phoenix, Arizona

Faculty Mentors

FURI Symposium Totals

TotalProjects

0

FacultyMentors

0

OnlineSymposia

0

ResearchFocus Areas

0

FURIStudents

0

MOREStudents

0

KEENStudents

0

GCSPStudents

0